AMARILLO BIOSCIENCES INC (OTCMKTS:AMAR) Shorted Shares Decreased By 38.64%

September 14, 2018 - By Jeanette Kaplan

The stock of AMARILLO BIOSCIENCES INC (OTCMKTS:AMAR) registered a decrease of 38.64% in short interest. AMAR’s total short interest was 2,700 shares in September as published by FINRA. Its down 38.64% from 4,400 shares, reported previously. With 11,800 shares average volume, it will take short sellers 0 days to cover their AMAR’s short positions.

It closed at $0.3025 lastly. It is down 0.00% since September 14, 2017 and is . It has underperformed by 15.62% the S&P500.

Amarillo Biosciences, Inc. engages in the development of biologics for the treatment of human and animal diseases. The company has market cap of $11.28 million. The firm owns or licenses five issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dietary supplement, Maxisal. It currently has negative earnings. It focuses on research for the treatment of human disease indications primarily influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: